CIK 0000318306 · Non-accelerated filer<br>Smaller reporting company
ABEONA THERAPEUTICS INC.
Sign in to watch- Ticker
- ABEO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 830221517
- Phone
- 646-813-4701
- Business address
- 6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
- Former names
- PLASMATECH BIOPHARMACEUTICALS INC, ACCESS PHARMACEUTICALS INC, CHEMEX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,397
- in 5 filings
Net −$296,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Seshadri Vishwas −$101K Chief Executive Officer sold 2% of stake
- Alvino Mark −$88K Director sold 19% of stake
- Vazzano Joseph Walter −$47K Chief Financial Officer sold 2% of stake
- O'Malley Brendan M. −$35K SVP, Chief Legal Officer sold 2% of stake
- Vasanthavada Madhav −$25K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-08 | Seshadri Vishwas Chief Executive Officer | Sale | −24,428 | $5.43 | $133K | 1,405,995 |
| 2026-06-08 | O'Malley Brendan M. SVP, Chief Legal Officer | Sale | −4,826 | $5.43 | $26K | 446,308 |
| 2026-05-26 | Alvino Mark Director | Gift | −500 | 77,065 | ||
| 2026-05-22 | Alvino Mark Director | Sale | −6,500 | $5.46 | $35K | 77,565 |
| 2026-05-15 | Crombez Eric Director | Sale 10b5-1 | −26,143 | $5.53 | $145K | 37,313 |
| 2026-05-11 | Vasanthavada Madhav Chief Commercial Officer | Sale | −5,548 | $5.96 | $33K | 313,071 |
| 2026-04-01 | Goldan Keith A. Director | Grant or award | +32,751 | 32,751 | ||
| 2026-03-31 | Seshadri Vishwas Chief Executive Officer | Sale 10b5-1 | −29,985 | $4.38 | $131K | 1,430,423 |
| 2026-03-16 | Vazzano Joseph Walter Chief Financial Officer | Sale | −785 | $4.76 | $4K | 567,775 |
| 2026-02-02 | Silverstein Christine Berni Director | Sale | −20,070 | $5.09 | $102K | 137,722 |
| 2026-02-02 | Wuchterl Donald A. Director | Sale | −14,814 | $5.09 | $75K | 167,935 |
| 2026-02-02 | Crombez Eric Director | Sale | −16,284 | $5.09 | $83K | 63,456 |
| 2026-02-02 | Alland Leila Director | Sale | −18,065 | $5.09 | $92K | 173,614 |
| 2026-02-02 | Alvino Mark Director | Sale | −2,000 | $5.09 | $10K | 84,065 |
| 2026-01-26 | Wuchterl Donald A. Director | Grant or award | +37,313 | 182,749 | ||
| 2026-01-26 | Zeiher Bernhardt G Director | Grant or award | +37,313 | 84,458 | ||
| 2026-01-26 | Crombez Eric Director | Grant or award | +37,313 | 79,740 | ||
| 2026-01-26 | Silverstein Christine Berni Director | Grant or award | +37,313 | 157,792 | ||
| 2026-01-26 | Amoroso Michael Director | Grant or award | +37,313 | 217,779 | ||
| 2026-01-26 | Charles Faith L. Director | Grant or award | +37,313 | 176,407 |
Page 2 of 12 · 223 trades